Q21* (p.Gln21Ter) variant of LAMA2 (Laminin subunit alpha-2)
Q21* (p.Gln21Ter) in LAMA2 (Laminin subunit alpha-2) is a protein-truncating change. Clinical records from EBI and UniProt describe it as pathogenic. The record also includes variant effect predictions, population frequency data, and published literature.
Q21* (p.Gln21Ter) variant details
- p.Gln21Ter
- rs886061039
- ClinGen CA365828264
- ClinVar RCV000673285
- ClinVar RCV002531335
- Pathogenic
- Stop Gained
- CADD 33.00
- EBI: Pathogenic
- UniProt: Pathogenic
- Population evidence available
- Cited in: LAMA2 Muscular Dystrophy. (PMID 22675738)
- Cited in: Consensus statement on standard of care for congenital muscular dystrophies. (PMID 21078917)